ICA, a Lactobacillus gallinarum‐derived metabolite, suppresses the key enzyme responsible for producing Kyn, competitively inhibits Kyn‐induced AhR activation, and ultimately enhances CD8+ T cell function to boost anti‐PD1 efficacy in CRC patients.28 The gene discussed is CD8A; the disease is colorectal carcinoma.